ArticlePDF Available

Síndrome de Sweet e policondrite recidivante reveladores de síndrome mielodisplásica

Authors:

Abstract and Figures

Certas dermatoses, pertencentes ao grupo das síndromes paraneoplásicas mucocutâneas, podem ser o prenúncio de uma neoplasia previamente não conhecida. Tanto a síndrome de Sweet como a policondrite recidivante incluem-se neste grupo. A síndrome de Sweet e a PR são raramente encontradas em um mesmo paciente. A presença de policondrite recidivante e síndrome de Sweet em um mesmo paciente tem se revelado mais frequente em pacientes com neoplasias associadas, sobretudo hematológicas. Relata-se o caso de paciente do sexo masculino, 79 anos, com síndrome de Sweet e policondrite recidivante, em quem, subsequentemente, foi diagnosticada uma síndrome mielodisplásica.
Content may be subject to copyright.
An Bras Dermatol. 2011;86(4Supl1):S173-7.
173
Sweet's Syndrome and relapsing polychondritis signal
myelodysplastic syndrome
Síndrome de Sweet e policondrite recidivante reveladores de síndrome
mielodisplásica
Filipa da Encarnação Roque Diamantino
1
Pedro Manuel Oliveira da Cunha Raimundo
2
Ana Isabel Pina Clemente Fidalgo
3
Abstract: The emergence of certain skin conditions belonging to the group of mucocutaneous parane-
oplastic syndromes may indicate the future appearance of a previously unknown malignancy. Sweet´s
Syndrome and relapsing polychondritis are included in this group. Sweet´s Syndrome and relapsing
polychondritis are very rarely found together in the same patient. This dual occurrence is more com-
monly found in cancer patients with associated hematological malignancies. We report the case of a 79-
year-old male with Sweet´s Syndrome and relapsing polychondritis, who was subsequently diagnosed
with a myelodysplastic syndrome.
Keywords: Polychondritis, relapsing; Sweet´s syndrome; Paraneoplastic syndromes
Resumo: Certas dermatoses, pertencentes ao grupo das síndromes paraneoplásicas mucocutâneas,
podem ser o prenúncio de uma neoplasia previamente não conhecida. Tanto a síndrome de Sweet como
a policondrite recidivante incluem-se neste grupo. A síndrome de Sweet e a PR são raramente encon-
tradas em um mesmo paciente. A presença de policondrite recidivante e síndrome de Sweet em um
mesmo paciente tem se revelado mais frequente em pacientes com neoplasias associadas, sobretudo
hematológicas. Relata-se o caso de paciente do sexo masculino, 79 anos, com síndrome de Sweet e poli-
condrite recidivante, em quem, subsequentemente, foi diagnosticada uma síndrome mielodisplásica.
Palavras-chave: Policondrite recidivante; Síndrome de Sweet; Síndromes paraneoplásicas
Received on 22.11.2010.
Approved by the Advisory Board and accepted for publication on 22.12.2010.
* Study undertaken at Dermatovenerology Department, Santo António Capuchin Hospital, Lisbon, Portugal.
Conflict of interest: None / Conflito de interesse: Nenhum
Financial funding: None / Suporte financeiro: Nenhum
1
MD, Resident in Dermatovenerology at the Santo António Capuchin Hospital, Lisbon, Portugal.
2
Internal Medicine Resident, St. Joseph´s Hospital, Lisbon, Portugal.
3
Specialist Doctor, Dermatology Department, Santo António Capuchin Hospital, Lisbon, Portugal.
©2011 by Anais Brasileiros de Dermatologia
CASE REPORT
INTRODUCTION
Certain dermatoses in the group of paraneo-
plastic syndromes may herald the appearance of a pre-
viously unknown malignancy. A study of these may
contribute to its early detection and treatment.
Sweet’s Syndrome (SS), first described in 1964
by Robert Sweet, is a rare and acute febrile neu-
trophilic dermatosis, the pathogenesis of which is not
entirely clear. The syndrome is characterized by sud-
den onset of erythematous infiltrated papules or
plaques, located especially on the face, neck and
upper extremities and associated with fever and neu-
trophilic leukocytosis.
1
It can be classified in five
groups: idiopathic or classic, parainflammatory, para-
neoplastic, linked to pregnancy and secondary to
drugs. Relapsing polychondritis (RP) is a rare multisys-
temic disease of unknown etiology, probably of an
immunologic nature, first described in 1923 by Jakch
Wartenhorst. RP is characterized by recurrent inflam-
mation and cartilage tissue destruction, including
nasal, auricular tissues and the upper airways.
2
An
increasing number of cases have been described as
being linked to malignancies, particularly myelodys-
An Bras Dermatol. 2011;86(4Supl1):S173-7.
plastic syndrome and, albeit less frequently, to solid
tumors or other hematologic malignancies.
3
Myelodysplastic syndrome (MDS) is a clonal
disorder of the hematopoiesis characterized by dys-
plastic bone marrow and peripheral cytopenia.
The report below describes the case of a
patient with Sweet's Syndrome and RP, who was sub-
sequently diagnosed with MDS.
CASE REPORT
79-year-old male white patient, monitored in
the Dermatology Department, suffering recurrent
episodes of sudden onset of erythematous, pseudo-
vesicular, circular plaques with slightly pink centers,
painful, varying in size from 0.5 to 3 cm, located on
the trunk, neck and upper limbs, always accompanied
by fever (37.5 to 38º C) (Figure 1). The review of sys-
tems was normal, with no evidence of organomegalies
or lymphodenomegalies. A skin biopsy showed edema
of the papillary dermis, a dense perivascular inflam-
matory infiltrate consisting predominantly of neu-
trophils, many with leukocitoclasia (Figure 2).
Histopathological findings were consistent with a
diagnosis of SS. The laboratory tests showed leukope-
nia (3400/µL) and an increased erythrocyte sedimen-
tation rate (50 mm/h). After steroid therapy was start-
ed (deflazacort 60 mg/day, with slow gradual with-
drawal), initial remission was observed, but the
lesions reappeared soon after suspension of therapy.
In order to evaluate the associated etiology the follow-
ing were performed: laboratory tests (liver, kidney
and thyroid function, tumor markers, viral serology,
ANA's, anti-DNA, anti-SSA, anti-SSB, anti-RNP, anti-SM),
bone marrow tests, upper GI endoscopy, colonoscopy,
simple chest X-rays, computerized axial tomography
of the chest, abdomen and pelvis, and abdominal,
prostate and thyroid gland ultrasound, which pro-
duced results within normal limits.
About 12 months after initial diagnosis of SS,
the patient complained of pain and swelling of the left
pinna. Physical examination revealed swelling, red-
ness and heat, except for the lobule (Figure 3A). An
auricular cartilage biopsy showed dense inflammatory
infiltrate in the subcutaneous cartilage and degenera-
tion of marginal chondrocytes consistent with chon-
dritis (Figures 3B, 3C and 3D). Concomitant episodes
of conjunctival injection (Figure 4) were diagnosed by
an ophthalmologist as bilateral peripheral superficial
corneal ulcers. The patient was medicated sympto-
matically.
The patient was monitored at the Dermatology
Clinic for 15 months. During this period he presented
with recurrent skin lesions consistent with SS, as well
as recurring episodes of inflammation in the eyes and
both ears. Received oral corticosteroids to deal with
the outbreaks, with complete remission of symptoms
until after completion of treatment. More recently the
patient has suffered weight loss and asthenia. Periodic
laboratory tests have detected non-megaloblastic
macrocytic anemia and neutropenia. Amyelogram and
bone marrow biopsy were done, with findings consis-
tent with Myelodysplastic Syndrome. The patient was
referred to the Hematology/Oncology Department.
DISCUSSION
Paraneoplastic dermatoses are non-neoplastic,
tumor-related visceral or hematologic skin disorders.
The possibility of predicting the coexistence of a neo-
FIGURE 1: Clinical manifestations of Sweet's Syndrome: erythema-
tous plaques with annular configuration and pseudovesiculation,
located on the back
FIGURE 2: A. Sweet's Syndrome (H&E x 40): Edema in the papillary
dermis and a dense perivascular inflammatory infiltrate; B. Infiltrate
composed of neutrophils with leukocitoclases (H&E x 400)
A
B
174 Diamantino F, Raimundo P, Fidalgo A
Sweet's Syndrome and relapsing polychondritis signal myelodysplastic syndrome 175
An Bras Dermatol. 2011;86(4Supl1):S173-7.
plasm from the study of mucocutaneous lesions with
certain characteristics arouses particular interest in
these dermatoses.
SS is related to cancer in 20% of cases, with 85%
of these linked to hematological disorders and 15% to
solid tumors. Association with MDS is common and
may signify a poor prognosis given the possibility of
conversion to acute myeloid leukemia.
The diagnosis of SS is based on clinical find-
ings, histology and laboratory tests, according to the
diagnostic criteria adapted by Su and Liu
1
(Table 1).
Our patient presented two major criteria (clinical
aspect of lesions and dense neutrophilic infiltrate in
the biopsy) and three minor criteria (fever, associated
sickness and response to corticosteroid therapy).
The paraneoplastic form of SS tends to present
more severe and atypical manifestations than the clas-
sic form. There is no predilection for either sex. The
skin lesions tend to be vesicular, bullous and some-
times necrotic and ulcerative. In addition to the usual
locations, the lesions also affect the lower limbs, trunk
and back. Systemic signs of neutrophilic leukocytosis
and fever may be absent, while clinical recurrences are
frequent.
4
Recurrent episodes of painful, well-demarcated
plaques, with pseudovesiculation, predominantly
located on the trunk, without neutrophilia, drew our
attention to a possible connection to underlying dis-
ease and we decided to monitor the patient closely.
MDS was diagnosed around two years after the onset
of the skin symptoms. The clinical and patient out-
comes reported confirm the data available in the liter-
ature. In a published review of 9 cases (all male
patients with atypical and recurrent skin lesions) MDS
was eventually diagnosed at all, 3.5 years (on average)
after onset of SS.
4
A B C
D
FIGURE 3: A. Left
pinna with hyper-
emia and edema in
the region cartilage,
not affecting earlobe:
B. Biopsy of cartilage
(H&E x 40); C.
Lymphoplasmacytic
inflammatory infil-
trate in the dermis
underlying the carti-
lage (H&E x 100); D.
Degeneration of mar-
ginal chondrocytes
(H&E x100)
Major criteria 1 - Abrupt onset of painful
erythematous plaques or nodules
2 - Dense neutrophilic exudate in the
biopsy
Minor criteria 1 - Fever with temperature over 38° C
2 - Association with hematologic
malignancy, inflammatory disease,
pregnancy, prior respiratory or
grastrointestinal infection
3 - Excellent response to treatment
with systemic steroids
4 - Abnormal lab values
CHART 1: Diagnostic criteria for Sweet's Syndrome - 2
major and 2 minor criteria required
FIGURE 4: Eye inflammation
Our patient was referred to the Oncology
Department for more aggressive treatment of MDS, in
the expectation of controlling the skin disease more
effectively.
The classic manifestation of RP is acute unilater-
al or bilateral auricular chondritis with the presence of
inflammatory signs sparing the earlobe, present in
39% of cases at diagnosis and manifested in 85% of
patients at some stage of the disease. Other frequent-
ly encountered clinical manifestations include nasal
cartilage alterations, arthritis, eye and tracheo-
bronchial tree symptoms. Approximately 30% of RP is
associated with an autoimmune or hematological dis-
ease.
2
The diagnosis of RP is mainly clinical, embody-
ing the criteria established by Damiani and Levine
2
(Table 2). The patient described had bilateral chondri-
tis of the pinna, superficial peripheral corneal ulcers
and ocular inflammation and compatible histopatho-
logic findings - all of which fitted the RP criteria. Eye
symptoms are the most common (present in 60% of
patients), with scleritis and episcleritis the most fre-
quently observed. In the literature we also found
cases associated with corneal ulcers, although these
are less common.
5
RP and SS are rarely found in the same patient.
Only 23 cases have been reported to date in the liter-
ature. Three of these cases concerned were from a
group of 48 Mayo Clinic patients with SS.
6
In a French
study involving 200 patients with RP, seven had SS.
7
In
a review of nine patients with SS and MDS, four of
them developed RP
4
.
Le Gal et al describe two cases of SS associated
with RP - one case associated with myelodysplasia and
the other preceding RP.
8
The other seven cases were
published separately. In these, SS preceded the
appearance of PR in two cases, occurred after its
appearance in four cases and was concomitant in one
case.
9-15
Twelve patients with SS and PR had associat-
ed neoplasia: MDS in 11 cases and bladder cancer in
one case.
Both SS and RP are included in the group of
mucocutaneous paraneoplastic syndromes associated
with hematologic malignancies. Our patient who was
diagnosed with SS and PR developed MDS. Although
uncommon, more than one paraneoplastic syndrome
has been described as affecting the same patient.
3
The
knowledge that both SS and RP could be the first signs
of progression to MDS should prompt clinicians seri-
ously to consider this hypothesis.
There has been some speculation in the literature
as to whether the association of SS and PR could be sim-
ply a coincidence in patients with hematologic malig-
nancies or whether both conditions might be etiological-
ly related.
13
For the moment, we await reports on a larg-
er number of cases documenting the occurrence of SS
and RP in patients with MDS before affirming that a
significant link indeed exists between them.
176 Diamantino F, Raimundo P, Fidalgo A
An Bras Dermatol. 2011;86(4Supl1):S173-7.
1 - Chondritis of pinna
2 - Nonerosive seronegative inflammatory polyarthritis
3 - Nasal chondritis
4 - Eye inflammation
5 - Respiratory tract chondritis
6 - Cochlear and/or vestibular dysfunction
CHART 2: Diagnostic criteria for relapsing polychondri-
tis (McAdam et al consider that it is necessary to take
into account the presence of 3 or more of the 6 items
below; Damiani and Levine consider the need for one
McAdam et al criterion + confirmatory histology)
McAdam et al consideram necessária a presença de 3 ou mais
dos seguintes 6; Damiani e Levine: 1 critério de McAdam et al
+ histologia confirmatória
Sweet's Syndrome and relapsing polychondritis signal myelodysplastic syndrome 177
An Bras Dermatol. 2011;86(4Supl1):S173-7.
REFERENCES
1. Su WPD, Liu HNH. Diagnostic criteria for Sweet’s syndrome. Cutis.1986;37: 167-74.
2. Damiani JM, Levine HL. Relapsing polychondritis – report of ten cases.
Laryngoscope. 1979;89:929-46.
3. Cohen RP. Swet’s syndrome and relapsing polychondritis: is their appearance in the
same patient a coincidental occurrence or a bona fide association of these
conditions? Int J Dermatol. 2004;43:772-7.
4. Vigno-Pennamen MD, Juillard C, Rybojad M, Wallach D, Daniel MT, Morel P et al.
Chronic recurrent lymphocyt Sweet syndrome as a predictive marker for
myelodysplasia: a report of 9 cases. Arch Dermatol. 2006;142:1170-6.
5. Peebo BB, Peebo M, Frennesson C. Relapsing polychondritis: a rare disease with
varying symptoms. Acta Ophtalmolo Scand. 2004;82:472:5.
6. Fett DL, Gibson LE, Su WPD. Sweet’s syndrome: systemic signs and symptoms
and associated disorders. Mayo Clinic Proc. 1995;70:234-40.
7. Frances C, El Rassi R, Laporte JL, Rybojad M, Papo T, Piette JC. Dermatologic
manifestations of relapsing polychondritis. A study of 200 cases at a single center.
Medicine. 2001;80:173-9.
8. Le Gal FA, Roux MF, Vignon-Pennamen MD, et al. Neutrophilic dermatosis
associated with relapsing polychondritis. Five cases. Ann Dermatol Venereol. 1997;
124:S170.
9. Astudillo L, Launay F, Lamant L, Sailler L, Basex L, Couret B, et al. Sweet’s
syndrome revealing relapsing polychondritis. Int J Dermatol. 2004;43:720-22.
10. Wastiaux H, Hervier B, Durant C, Gagey-Caron V, Masseau A, Barbarot S, Hamidou
M. Sweet’s syndrome as the presenting manifestation of relapsing polychondritis.
Rev Med Interne. 2010;314:e1-3.
11. Fujimoto N, Tajima S, Ishibashi A, Ura-Ishikou A, Manaka I. Acute febrile
neutrophilic dermatosis (Sweet’s syndrome) in a patient with relapsing
polychondritis. Br J Dermatol. 1998;139:930-1.
MAILING ADDRESS / ENDEREÇO PARA CORRESPONDÊNCIA:
Filipa da Encarnação Roque Diamantino
Serviço de Dermatologia
Hospital de Santo António dos Capuchos
Alameda Santo António dos Capuchos
1150 - 314 Lisboa - Portugal
E-mail: filipadiamantino@hotmail.com
How to cite this article/Como citar este artigo: Diamantino F, Raimundo P, Fidalgo A. Sweet's Syndrome and
relapsing polychondritis signal myelodysplastic syndrome. An Bras Dermatol. 2011;86(4 Supl 1):S173-7.
12. Matzkies FG, Manger B, Schimtt-Haendle M, Nagel T, Kraetsh HG, Kalden JR, et al.
Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after
initiation of treatment with infliximab. Ann Rheum Dis. 2003;62; 81-2.
13. Kawakami T, Kawase A, Takeuchi S, Yoshioka S, Fujimoto N, Tajima S, et al. Sweet
syndrome subsequent to relapsing polychondritis and myeloysplastic syndrome in
a Japanese patient. Acta Derm Venereol. 2008; 88: 517-9.
14. Fraisse T, Brunel AS, Arnaud E, Balducchi JP, Jourdan J, de Wazières B, et al.
Original presentation of relapsing polychondritis: four cases. Rev Med Interne.
2008; 29: 801-4.
15. Vestergaard C, Soelvsten H, Ramsing M, Hansen ES, Deleuran M. Concomitant
Sweet’s syndrome and relapsing polychondritis. Acta Derm Venereol.
2007;87:426-55
... Sweet syndrome was first identified in 1964 by Robert Sweet as a febrile neutrophilic dermatosis with acute onset, with an unclear pathogenesis [1]. He described the cases of eight women with skin eruptions that resembled erythema multiforme, which is associated with leukocytosis, mainly neutrophil polymorphonuclears and fever. ...
... It was initially classified into five groups: classic, parainflammatory, paraneoplastic, associated with pregnancy and secondary to drug administration [1], but it has been categorized by more recent articles into classical SS, malignancy-associated SS (MASS) and drug-induced SS (DI-SS) [5]. Drugs that have been classified as SS inducers are shown in Table 1 [6]. ...
... Chronology in the diagnostics of SS related to myeloproliferative disorders can be difficult. In case 3 [1], dermatological recurrent episodes showed early leukopenia at first with a shift in complete blood count that occurred after 15 months in association with non-megaloblastic macrocytic anemia and neutropenia. ...
Article
Full-text available
Sweet syndrome (SS) is a rare disease described as a febrile neutrophilic dermatosis with acute onset, the pathogenesis of which has not yet been elucidated. The syndrome is characterized by the sudden onset of erythematous infiltrated papules or plaques located on the upper body and is associated with fever, leukocytosis and neutrophilia. The lesions show a dense dermal infiltration with mature neutrophils. The condition is responsive to systemic steroids. The central nervous system, bones, muscles, eyes, ears, mouth, heart, lung, liver, kidneys, intestines, and spleen may be affected by SS as extracutaneous manifestations. More and more cases have been found to be associated with malignancies, particularly myelodysplastic syndrome, and, less frequently, other hematologic malignancies or solid tumors. Approximately 21% of patients with SS have an associated malignancy and up to 80% of MASS cases are associated with hematological diseases, predominantly myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Myelodysplastic syndrome is a clonal disease of the bone marrow characterized by inefficient hematopoiesis, dysplasia of the bone marrow and peripheral cytopenias. Affected patients have a high risk of leukemic transformation. After analyzing later studies and current practical aspects regarding MDS-related SS, we suggest an algorithm for evaluating these patients.
... Foram baseados nos achados clínicos, na histologia e nos exames laboratoriais. A doença é definida pela presença de dois critérios maiores -aparecimento abrupto de placas ou nódulos eritematosos e dolorosos e infiltração dérmica neutrofílica sem sinal de vasculite -e de pelos menos dois critérios menores dentre os seguintes: febre acima de 38ºC; infecção do trato respiratório ou do trato gastrointestinal anterior ao quadro ou associação com vacinação, doença inflamatória, neoplasias ou gestação; presença dos seguintes achados laboratoriais (três dos quatro): VHS acima de 20mm; proteína C reativa positiva; contagem de leucócitos acima de 8.000; mais de 70% de neutrófilos no hemograma e excelente resposta ao tratamento com corticoides ou iodeto de potássio [7][8][9] . ...
... Diferente da idiopática, não tem predileção por sexo e as lesões cutâneas são mais graves, tendem a ser vesiculosas, bolhosas ou mesmo necróticas e ulcerativas. O envolvimento extracutâneo e a ausência de neutrofilia ocorrem em mais da metade dos casos, já as recorrências clinicas são mais frequentes e concomitantes com as recidivas tumorais 4,8,10 . ...
Article
Full-text available
Introdução: A sindrome de Sweet é uma dermatose neutrofílica que apresenta lesões cutâneas agudas na forma de placas e nódulos eritemato edematosos. Outras alterações como febre, leucocitose periférica, artralgia, mialgia, cefaléia, acometimento ocular, oral e de órgãos internos podem ocorrer. O objetivo deste trabalho é discu- tir o quadro clínico, critérios diagnósticos, abordagem investigativa e possíveis tratamentos para esta enfermidade. Caso Clínico: Paciente, sexo feminino, 45 anos, branca, com sindrome de Sweet idiopática tratada com glicocorti- cóides. Ao exame, apresentava placas eritematosas, edematosas com pseudovesiculação na face, tronco, membros superiores e inferiores. O exame histopatológico mostrou intenso edema, infiltrado de neutrófilos, leucocitoclasia e extravasamento de hemácias na derme superior. Discussão: A sindrome de Sweet pode estar relacionada ao uso de medicamentos, gestação, inflamações, infecções e malignidades. As neoplasias mais frequentemente associadas são as hematológicas, em especial a leucemia mielóide aguda. Apesar de os glicocorticóides serem tratamentos de elei- ção na sindrome de Sweet, existem outras alternativas terapêuticas. PALAVRAS-CHAVE – Síndrome de Sweet; Síndrome paraneoplásica; Dermatose neutrofílica.
Article
Relapsing polychondritis, or RP, is a rare connective tissue disease characterized by relapsing-remitting destructive inflammation of the cartilaginous and other proteoglycan-rich structures in the body. Given the relatively low incidence of RP, a concise clinically relevant guide, focusing on the cutaneous manifestations of this serious disease, is lacking. In this review, we provide the dermatologist with an approach to diagnosing RP and a guide to its initial work-up, and management. We close with an overview of the currently available treatment modalities for RP.
Article
The diagnosis of Sweet's syndrome rests on a combination of clinical symptoms and characteristic physical and pathologic features. Patients typically have fever and tender erythematous skin lesions (papules, nodules, or plaques). Neutrophilia, high levels of serum inflammatory markers, and diffuse mature neutrophil infiltration localized to the upper dermis are the most important findings. Sweet's syndrome was first described by Robert Sweet in 1964, whose sentinel paper described 8 women with fever, leukocytosis, and erythematous plaques infiltrated by neutrophils. Subsequently, extracutaneous sites were included in the diagnosis. This review of publications between 1964 and April 2012 found 1683 reports of Sweet's syndrome of which only 8 were published between 1964 and 1969, after which the number of the papers grew by decades to 59, 228, 459 and 692. With more articles, there are more reports of malignancy-associated Sweet's syndrome. This may reflect the awareness by physicians of the disease and of the drugs which may cause it. There is considerable overlap in the constitutional findings of Sweet's syndrome and malignant disorders. It is crucial that the possibility of Sweet's syndrome be included in a hematologist or oncologist's differential diagnosis of fever and skin lesions.
Article
Full-text available
RD Sweet first described an acute febrile neutrophilic dermatosis in 1964 characterised by acute onset, fever, leucocytosis, and erythematous plaques.1 Skin biopsy specimens show infiltrates consisting of mononuclear cells and neutrophils with leucocytoclasis, but without signs of vasculitis. Sweet’s syndrome is frequently associated with solid malignancies or haemoproliferative disorders, but associations with chronic autoimmune connective tissue disorders have also been reported.2 The aetiology of Sweet’s syndrome is unknown, but evidence suggests that an immunological reaction of unknown specificity is the underlying mechanism. A 51 year old white man with relapsing polychondritis (first diagnosed in 1997) was admitted to our hospital in June 2001 with a five week history of general malaise, fever, recurrent arthritis, and complaints of morning stiffness. Besides autoimmune polychondritis, he had insulin dependent diabetes mellitus that was diagnosed in 1989. On admission, he presented with multiple small to medium, sharply demarked, raised erythematous …
Article
Full-text available
Purpose: Relapsing polychondritis (RPC) is a rare systemic disease affecting primarily cartilaginous and proteoglycan-rich structures. It is a potentially fatal disease with unknown aetiology. There are no specific tests for RPC. The diagnosis is dependant on clinical criteria, which include chondritis of both auricles, non-erosive inflammatory polyarthritis, nasal chondritis, ocular inflammation, respiratory tract chondritis and cochlear and/or vestibular damage. Ocular symptoms will occur in approximately 60% of RPC patients. As an example, a patient with signs of RPC is described. Methods/Result: A 30-year-old woman was referred to our department for evaluation of a central corneal ulcer in the left eye. She had a history of recurrent pain in both her auricles and was also found to have a nasal septum perforation. Relapsing polychondritis was suspected. Conclusion: Non-healing corneal ulcers should alert the ophthalmologist to look for unusual reasons for this condition. RPC is one possible cause.
Article
Objective: To characterize the findings associated with acute febrile neutrophilic dermatosis (Sweet's syndrome [SS]) and the response of SS to treatment. Design: We retrospectively reviewed 48 cases of SS encountered at the Mayo Clinic between 1980 and 1992. Material and Methods: Histopathologic specimens and medical records were studied to determine initial manifestations, patterns of involvement, systemic signs and symptoms (including mucosal, musculoskeletal, hematologic, pulmonary, hepatic, and renal findings), and conditions associated with SS. Results: In patients with SS, the typical manifestations are the acute onset of tender, erythematous or violaceous nodules or plaques in association with fever, leukocytosis, and dermal neutrophilia. In our study group, the cutaneous lesions most frequently involved the arms and legs. Of our 48 patients, 26 (54%) had a hematopoietic, plasma cell, or malignant disorder, and many of these patients had associated anemia, especially the male patients. No single laboratory finding specifically indicated an association with serious systemic disease. Most patients were treated with a tapering dose of prednisone, which yielded a good response. Conclusion: Clinical acumen and appropriate laboratory tests are the main requirements for detection of hematologic disorders, internal malignant diseases, or other systemic conditions associated with SS.
Article
Relapsing polychondritis (RP) is a rare disorder characterized by recurrent inflammatory episodes involving various cartilages. The clinical course of RP is variable, and dermatologic manifestations are uncommon. We report a 73-year-old patient who presented with a neutrophilic dermatosis (Sweet's syndrome) as the initial manifestation of RP. There was no evidence for a myelodysplastic syndrome, as it has been previously reported with RP, but the patient was followed-up for an indolent and untreated chronic lymphocytic leukaemia. Complete remission was obtained with oral corticosteroids. This report highlights the clinical spectrum of the RP. Copyright 2010 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.
Article
Relapsing polychondritis is a rare disease of unknown etiology. There are approximately 211 reported cases in the world literature. This is a report of ten cases from the Cleveland Clinic Foundation. McAdam's diagnostic criteria for R.P. were reviewed and modified. For diagnosis, all patients had to have 1. at least three or more diagnostic criteria, histologic confirmation not necessary; 2. one or more of McAdam's signs with positive histologic confirmation; or 3. chondritis in two or more separate anatomic locations with response to steroids and/or Dapsone. Chondritis of the auricles (9/10 patients) and arthropathy (8/10 patients) are the most common presenting signs. Chondritis was also seen in the nose (6/10) and the upper respiratory tract involving the larynx and trachea (4/10). Cochlear and vestibular damage and ocular inflammation were each seen in 5/10 patients. Patients were treated with steroids and/or Dapsone. Both drugs were reliable in abating episodes of activity and in decreasing recurrences. These results further support Dapsone as an alternate form of treatment for RP.
Article
Five patients with Sweet's syndrome with typical clinical and histologic features were reviewed. Attention is drawn to the possible association of drug use, venipuncture and insect bite, resection of colon, exacerbation of sinusitis, and acute myelocytic leukemia with the onset of the skin eruptions in our patients. The question of whether Sweet's syndrome is just a reactive phenomenon or a specific entity is raised. Our opinion is that Sweet's syndrome is a reaction to many different antigens. However, characteristic clinical and histologic features are present to allow a definite diagnosis of Sweet's syndrome. We propose two major criteria and four minor criteria for the diagnosis of Sweet's syndrome. Findings in patients must fulfill both of the major criteria and at least two of the minor criteria to allow a diagnosis of Sweet's syndrome.
Article
Dermatologic manifestations of relapsing polychondritis (RP) have been relatively poorly studied compared to other manifestations. In this study we describe dermatologic manifestations in a large series of patients with RP and the corresponding pathologic findings. In this retrospective, single-center review of 200 patients diagnosed with RP according to Michet's criteria, we analyzed separately those suffering from associated diseases with potential dermatologic involvement or chronic dermatitis. Skin or mucosal biopsies taken from 59 patients were examined without knowledge of the clinical data. Among the 200 patients with RP, 73 had chronic dermatitis or associated diseases with potential dermatologic involvement, especially hematologic disorders (n = 24) and connective tissue diseases (n = 22). Among the other 127 patients, 45 (35.4%) had dermatologic manifestations: aphthosis (n = 21; oral in 14 and complex in 7), nodules on the limbs (n = 19), purpura (n = 13), papules (n = 10), sterile pustules (n = 9), superficial phlebitis (n = 8), livedo reticularis (n = 7), ulcerations on the limbs (n = 6), and distal necrosis (n = 4). Dermatologic manifestations were the presenting feature of RP in 15 cases (12%), and appeared concomitantly (n = 23) or not (n = 22) with attacks of chondritis. Histologic findings included vasculitis (n = 19, leukocytoclastic in 17 and lymphocytic in 2), neutrophil infiltrates (n = 6), thrombosis of skin vessels (n = 4), septal panniculitis (n = 3), and minor changes (n = 2). Patients with and without dermatologic manifestations did not differ with regard to male/female ratio; age at RP onset; frequency of auricular, nasal, or tracheobronchial chondritis; or frequency of rheumatologic, ocular, audiovestibular, renal, arterial, or venous involvement. The frequency of dermatologic manifestations (91% versus 35.4%; p < 0.0001), sex ratio (18 male/4 female versus 44 male/83 female, p < 0.0001), and age at first chondritis (63.3 +/- 14 yr versus 41.4 +/- 17 yr; p < 0.0002) were significantly higher in the 22 patients with myelodysplastic syndrome than in the 127 patients without any associated disease. In conclusion, although dermatologic manifestations occur frequently in patients with RP, especially in association with myelodysplasia, they are nonspecific and sometimes resemble those observed in Behçet disease or inflammatory bowel diseases. Their presence in the elderly warrants repeated blood cell counts to detect a smouldering myelodysplasia.